Navigation Links
Dohmen’s BioSoteria Calls for Abstracts for its Seventh Annual Pacific Drug Safety Summit (PDSS)

Emeryville, CA, (PRWEB) May 31, 2013

Dohmen’s BioSoteria Calls for Abstracts for its Seventh Annual Pacific Drug Safety Summit (PDSS)

September Conference Draws Global Biopharmaceutical Drug Safety and Medical Communications Decision-Makers to San Francisco

Emeryville, CA, May 28, 2013 -- BioSoteria, Drug Safety and Risk Management Specialists, and organizers of the Annual Pacific Drug Safety Summit (PDSS), have launched the PDSS website and now invite abstract submissions for oral presentations for the main conference or pre-conference tutorial at the 7th Annual PDSS. The conference will be held on September 19-20, 2013 at the Hilton San Francisco Airport Bayfront, Burlingame, CA.

“PDSS has rapidly grown, becoming one of the most well attended drug safety conferences in the US, drawing participants from the US, Europe, Latin America and Asia. Our speakers are pharmaceutical/biotechnology industry thought leaders who share a passion for excellence in practice and education, and bring a global perspective to the challenges faced in this dynamic regulatory environment,” said James Buchanan, PharmD, BioSoteria Senior Vice President, Pharmacovigilance and Risk Management. “The breadth and depth of experience among our speakers and attendees makes for a dynamic learning environment and networking opportunity. We invite you to express your interest in providing an oral presentation by submitting an abstract to the PDSS website.”

Sponsored pre-conference tutorials will be held on September 19, 2013 and oral presentations will take place during the main conference on September 20, 2013. Speakers are encouraged to submit an abstract based on their work in the area of pharmacovigilance, risk management, pharmacoepidemiology, medical communications, and/or adverse event intake and reporting. Case studies and examples that demonstrate this year’s theme, “Strategies that Drive Quality in Patient Safety and Operational Efficiency” are of particular interest.

PDSS is held annually in San Francisco, home to the largest cluster of life sciences companies in the United States. This year medical communications and adverse event reporting topics have been added to the agenda, including a discussion about the benefits of integrating safety and medical information operations for seamless communication and operational efficiency.

Previous PDSS Conference Topics:

  •     Globalization of Pharmacovigilance Practices
  •     Generic Product Safety Practices
  •     Patient Reported Outcomes in Clinical Research
  •     Quality Measures of Patient Safety
  •     Updates on Pharmacovigilance Regulations in EU, Latin America, and Asia

Previous PDSS Conference Speakers:

  •     Hugh Tilson, MD, DrPH, Adjunct Professor of Public Health Leadership, Epidemiology, and Health Policy, UNC Gillings School of Global Public Health
  •     Rebecca Wang, MD, Head of Drug Safety, Roche Global Pharma Development Center, China
  •     Valerie Simmons, MD, BS, FFPM, Lilly QPPV Executive, Global Patient Safety, Eli Lilly & Co Ltd, UK
  •     James Cross, PhD; Integrated Safety Risk Manager, Genentech
  •     Judith Zander, MD; Executive Director, Patient Safety, AstraZeneca
  •     Paul Coplan, Sc.D, MBA, Senior Director, Risk Management, Global Safety Surveillance and Epidemiology, Wyeth Pharmaceuticals
  •     Robin Geller, PhD; Director of Risk Management, Global Pharmacovigilance, Baxter Healthcare Corporation
  •     Catherine Hardalo, MD, VP, Clinical Development, Cadence Pharmaceuticals
  •     Tobias Peschel, MD, PhD, MBA, VP, Drug Safety & Public Health, Gilead Sciences
  •     Dorcie McKniff Jasperse, PhD; Executive Director Life Sciences, Raland Technologies
  •     Lisa Lawrence-Miyasaki, Senior Director, Global Clinical Development & Medical Affairs (GCD&MA) Drug Safety, Santen Inc.
  •     Mary Ellen O’Banion, RN, Director Drug Safety, Watson Pharmaceuticals
  •     Lauret Ballsun, RN, Principle, LBC Pharmaceuticals, LLC
  •     Juliane Mills, MT(ASCP) CLS(NCA), Senior Project Manager, Safety, Epidemiology, Registries, and Risk Management, United BioSource Corporation
  •     Shelley Gandhi, Director, Pharmacovigilance and Drug Safety; NDA Regulatory Science Ltd., UK
  •     E. Stewart Geary, Vice President and Deputy Director; Easai Co. Ltd., Tokyo, Japan
  •     Marisa Fernandes, RN, BSN; Manager, Drug Safety Center Latin America, PRA International
Those interested in providing an oral presentation during the main conference day may submit an abstract for consideration by the PDSS Program Committee at

For those corporate sponsors who wish to host a pre-conference tutorial, please submit your tutorial topic and outline for consideration to Penny Bemus at pbemus(at)dohmen(dot)com or call 636-519-2758.

Submissions are due by June 21, 2013.

About BioSoteria
Founded in 2007, and acquired by Dohmen in 2012, BioSoteria, serves the outsourcing needs of the pharmaceutical industry. From strategic risk management consulting services and full-service drug safety operational capabilities to world-class award winning pharmacovigilance training and education programs, BioSoteria provides unmatched experience, expertise, and leadership to support your company’s efforts to maximize your product’s benefit-risk profile. For more information and to learn more about BioSoteria’s drug safety services and training programs please visit

About Dohmen: Founded in 1858, Dohmen is a privately-held, Life Science Services Company, focused on creating a more efficient, affordable and accessible healthcare supply system. As the trusted partner to more than 600 Biopharma and Medtech innovators, Dohmen propels start-up, mid-tier and Fortune 500 companies with support services that span the commercialization continuum from pre-approval regulatory consulting to in-home patient services. With a tradition of innovation that spans over 155 years, we’re driven by the desire to reduce cost and complexity within today’s healthcare system, using a progressive model that connects life science companies with the patients they serve.

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. ASDSA Calls on Nevada Governor to Sign Under-18 Indoor Tanning Restrictions
2. Hockey Training Pro Calls out Lazy Hockey Players!
3. Mirena IUD Lawsuit Update: Judge Calls for More Input from Female Lawyers, Notes Rottenstein Law Group LLP
4. Cellphone Calls During Blood Pressure Readings May Skew Results
5. Hastings Center calls on health care professionals and organizations to meet standards for good care near the end of life
6. US Drug Watchdog Now Calls Transvaginal Mesh For US Women A Stunning National Tragedy And They Urge Victims To Call Them For The Names of National Caliber Women Attorneys
7. Hip Replacement Lawsuit Website Launched by Bernstein Liebhard LLP to Provide Updated Information on Hip Replacement Recalls, Growing Metal Hip Implant Litigation
8. Hate Other Peoples Cellphone Calls? Youre Not Alone
9. National commission calls for phasing out of fee-for-service pay within 5 years
10. Jonny Bowden Calls French Fries and Soda the “Two Worst Foods in the World”
11. Report Calls for Better U.S. Efforts to Fight Counterfeit Drugs
Post Your Comments:
(Date:6/26/2016)... ... 26, 2016 , ... Brent Kasmer, a legally blind and certified personal trainer is helping to ... app. The fitness app plans to fix the two major problems leading the fitness industry ... fits all type program , They don’t eliminate all the reasons people quit ...
(Date:6/25/2016)... D.C. (PRWEB) , ... June 25, 2016 , ... ... discuss health policy issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, ... their work on several important health care topics including advance care planning, healthcare ...
(Date:6/25/2016)... ... 2016 , ... The temporary closing of Bruton Memorial Library on June 21 due to a ... new, often overlooked aspect of head lice: the parasite’s ability to live away from a ... occurrence, but a necessary one in the event that lice have simply gotten out of ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... Oklahoma (PRWEB) , ... June 25, 2016 , ... ... both athletes and non-athletes recover from injury. Recently, he has implemented orthobiologic procedures ... Oklahoma City area —Johnson is one of the first doctors to perform the ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... 2016 Research and Markets has announced ... Diagnostic Tests" report to their offering. ... The World Market for Companion Diagnostics covers ... Market analysis in the report includes the following: ... Diagnostic Kits) by Region (N. America, EU, ROW), 2015-2020 ...
(Date:6/24/2016)... 2016  Arkis BioSciences, a leading innovator in ... durable cerebrospinal fluid treatments, today announced it has ... is led by Innova Memphis, followed by Angel ... investors.  Arkis, new financing will accelerate the commercialization ... release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
Breaking Medicine Technology: